KN

Kantilal Nathabhai Lodhiya

Director Director DIN 09052174
DIN 09052174 First appointment Feb 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2021
Shareholding value •••• Premium profile

About Kantilal Nathabhai Lodhiya

Data last updated:

Kantilal Nathabhai Lodhiya was a Director at Prolove Pharma Private Limited (2021–2025) and Director at Vargas Pharma Private Limited (2021–2022). The companies operate in Chemicals.

DIN 09052174
Primary Designation Director
Industry Chemicals
First Appointment 03 Feb 2021

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Prolove Pharma Private Limited U24296GJ2021PTC124109
Director14 Jul 20212021₹9.3 Lakh (FY 2024)Active
Vargas Pharma Private Limited U24299GJ2021PTC119962
Director03 Feb 20212021₹15.3 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Prolove Pharma Private Limited
Vargas Pharma Private Limited
Premium access

Shareholding and investment profile for Kantilal Nathabhai Lodhiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kantilal Nathabhai Lodhiya

Kantilal Nathabhai Lodhiya was first appointed on 03 Feb 2021 as Director at Vargas Pharma Private Limited.

Kantilal Nathabhai Lodhiya held 2 earlier board appointments: Prolove Pharma Private Limited (Director, 14 Jul 2021 to 20 Jul 2025); Vargas Pharma Private Limited (Director, 03 Feb 2021 to 09 Feb 2022).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available